International Medical Devices Share Discussion Threads

[8trader] 29/1/2008 15:55

Down again.

Such excellent news is totally wasted in a small cap when there is
such a large seller, had there been no seller the price would have
easily been trading in the 3-4 region.
The good side of a overhang is you get the chance to buy any amount
of stock at a very cheap price, currently 2.45p, when that overhang
clears and people cant buy no more than nms without paying a premium
then the price will rocket.
Profitable and with strong growth and today deals it's a great buy at
these prices, if you buy in size you have to hold as you wont be able
to sell at quoted prices until the overhang clears.

[8trader] 29/1/2008 12:30

Wins have a seller.

You can buy 200k at 2.5p but cant sell online.

Just like many small caps, they need to clear a overhang before
they will move up.

[safman] 29/1/2008 11:59

also bear in mind that this is "probably" one set of approved products.. key thing is that it may be competing against another.. so is it "exclusive"..

saffy..

[rbcrbc] 29/1/2008 11:48

I bought in at 5.66p, just wondering if this is going to be significant... and/or if I should top up.

[safman] 29/1/2008 11:48

"I note that they didn't give any sales forecasts numbers or values."

that is the drawback.. from my experience this is low-cost / low margin.. but selling would be in such vast quantities that you would be able to make a decent profit ..

If this is the standard in the NHS .. i would presume sig.. the key market still however would be the U.S .. many companies have tried, and failed.. so its not exactly an easy market, however those companies had mkt caps based on their potential, and at multiples of the mkt cap of INT..

However i don't know enough on INT to make a judgment, one thing for sure their product must be good in order to be accepted in the entire NHS trusts..

will be taking a further look...

saffy..

[8trader] 29/1/2008 11:44

RBCRBC.

Going to be hard to predict sales so early when they've yet to sell
the product ?

Even if it is low margin if it adds on more to what they are already
making plus the usual growth then the stock is very cheap, from recent
results, there is debt and loans just to be fair on the argument.

Highlights

* Turnover up 195% to #11.2 million from #3.8 million
* Profit after tax of #538,000 (from a loss of #360,000 in 2006)
* Gross profit margin up to 41% from 36% (2006)
* Acquisitions of two companies adding to a growing portfolio
* Renewal of existing distribution agreements, and new distribution
agreements signed
* Three companies integrated into one operation located in Selby, Yorkshire

[rbcrbc] 29/1/2008 11:40

I note that they didn't give any sales forcasts numbers or values.
I assume it would be a low cost and low margin item.

Any one got any ideas of the UK market size and profit potential ?

[ladyfarmer] 29/1/2008 11:35

Level 2 shows just 4 x 5000 sell orders - but agree that's not the full picture.

Surely past 4p. This is a huge advance and potential for other products and other markets

[ljsquash] 29/1/2008 11:31

A lot of the sells showing would have been early Buys and just now updating the trades.
Great news and not before time!
Lets hope we can get back to 4p + fairly quickly.

[8trader] 29/1/2008 11:27

lol

Some trader has already sold, they expect trades to move into profit
in 10 mins and if they dont they bail.
I think it's a buy too but there's a overhang as normal with most penny
stocks.

[ladyfarmer] 29/1/2008 11:24

This is a no-brainer. Have topped up again (purchases described as sells at 2.50 -2.61) Hold tight and good luck all.

[safman] 29/1/2008 11:19

"Currently, each of the 280 NHS Trusts are paying out an average of £600,000 per
annum to staff who have harmed themselves as a result of accidental needle
injuries including eight nurses who have tragically contracted HIV."

that would work out to be a huge saving on behalf of the NHS.. there may well be an overhang of the stock.. but that looks sig.. on the top of it..

the other type concept would be the needless syringe using either pressurized nitrogen or oxygen..

there is an overhang of stock..but v interesting.. adding to my watchlist and will view website..

cheers

saffy..

[cyberpost] 29/1/2008 11:05

The fact that NHS have approved it implies that other hospitals in europe and the US is easily accessible and potential big customers.

[8trader] 29/1/2008 11:01

Looks a good deal to me.

Company is profitable, cash is tight though but director took shares
instead of pay at much higher prices recently.

As usual there's a overhang, i'm actually ok with this one, looks
good value to me but can they clear the overhang ?

[safman] 29/1/2008 10:58

i have'nt got too much time to read through the story here, but provisions for the needle throughout the entire NHS trust sounds pretty significant.. 2 other companies i know tried and failed..actually make that 3..

good luck..

saffy..

[safman] 29/1/2008 10:45

buying at bottom..

saffy..

[bubble pricker] 25/1/2008 13:04

another dog.

[ladyfarmer] 07/12/2007 08:56

Dilution positive if caused by the right people coming on board at right price.

Yes, diluted but a smaller share of a more valuable co in my view so minus 12% share of a 30% + gain in the co's valuation = positive for me and I topped up a few at 3.30.

[ged5] 07/12/2007 08:47

12% dilution offset by the director remuneration at 4p and 5p.

Short term - no movement
Long term - could make headway towards the target price.

[james t kirk] 07/12/2007 07:55

Well it certainly suggests there are further aquisitions immenent as they raised money in July and are supposed to be profitable, so the extra cash must have a purpose, you would hope.

[pomp circumstance] 07/12/2007 07:25

good news!!! (or is it!!)


7 December 2007



International Medical Devices plc

("IMD" or "the Company")



Directors Remuneration and Convertible Loan Note



International Medical Devices plc (AIM: INT), the medical supply company
targeting the acute care, aged care, and devices markets, announces that its new
CEO has agreed to take part of his remuneration in shares above the current
market price, and that it has signed a convertible loan note.



Bill McGrath joined the company as Chief Operating Officer on 2 November 2007,
and became the Company's Chief Executive Officer on 3 December 2007. He has
agreed to convert, in aggregate #70,000 of his remuneration into Ordinary
Shares, at a price higher than today's market price, being 1,125,000 Ordinary
Shares at 4p and 500,000 Ordinary Shares at 5p, being a total of 1,625,000
Ordinary Shares.



The Company has also entered into a two year loan note with Trafalgar Capital
Specialized Investment Fund amounting to #600,000 which carries conversion
rights into Ordinary shares. IMD intends to utilise the funds in support of the
Company's "buy and build" strategy, relating to potential acquisition
opportunities. The provider has been issued 329,272 Ordinary Shares on entering
into the agreement.



Application has been made for the above 1,954,272 Ordinary Shares to be admitted
to trading on AIM. It is expected that admission to trading on AIM will be
effected and dealings in these new Ordinary Shares will commence on 13 December
2007.

[jotoha1] 05/12/2007 12:42

About time to, far to many scully wags in Aim already, hope you guys do well now!!!!

[james t kirk] 03/12/2007 07:52

Chris Thomas leaves by mutual consent - I'm sure certain posters will be pleased about that. Markets seem quite pleased too by early mark up..

[ged5] 16/11/2007 10:10

I must admit - I missed this announcement yesterday. On the surface it looks like they're making progress and fulfilling promises made in the results (about time too).

"Currently the Surety Needle is being evaluated by the South West Ambulance
Service NHS Trust and at Papworth Hospital. IMD will formally launch its Surety
Needle at the Dusseldorf Medica exhibition in November, and this will be the
first product under the 'Surety' brand. Previously this product was referred to
as 'Clip-On', and formed part of the intellectual property acquisition by IMD in July 2005. It is our intention to launch other complimentary safety intravenous injection and phlebotomy devices under this brand over the next 18 months."

I wonder what happened at Papworth Hospital!